Navigation Links
The Benefits of abciximab with clopidogrel for percutaneous coronary intervention Questioned

Primary findings from the Intracoronary Stenting and Antithrombotic Regimen-Rapid// Early Action for Coronary Treatment Trial (ISAR-REACT) has indicated that abciximab use in patients undergoing percutaneous coronary intervention (PCI) after pretreatment with 600 mg clopidogrel for less than 2 hours offered no clinically measurable benefit at 30 days.

The trial included 2159 patients undergoing PCI for stable or unstable angina without marked ST-segment changes or positive biomarkers, who were randomly assigned to receive abciximab or placebo. Results after a 1 year follow up indicated that death, myocardial infarction (MI), or target vessel revascularization occurred in 23.8% of patients randomly assigned to either treatment. The combination of death and MI also occurred similarly, at 6% in the abciximab group and 6.4% in the placebo group, as did death alone, at 2.1% and 2.4%, respectively. No trend towards benefits was seen in any patient subgroup analyzed.

Although data on platelet inhibition has suggested that antithrombotic protection with clopidogrel plus abciximab would be more effective than clopidogrel alone , the results of ISAR-REACT at both 30 days and 1 year, reveal that the expected difference in in vitro inhibition of platelet aggregation did not translate into a difference in the clinical outcomes between patients treated with one versus both agents say researchers .

For more information read:

http://www.medindia.net/interactives/
angioplasty.asp


http://www.medindia.net/patients/
patientinfo/chestpain_treatment.htm

'"/>





Page: 1

Related medicine news :

1. Benefits in fertility procedures
2. Benefits of Vitamin Supplements Unclear
3. Benefits of Eating Whole Grains, Fruits and Vegetables
4. Benefits of Nitric Oxide in the Treatment of Premature Infants
5. Benefits and Risks of Asthma Treatment Questioned
6. Benefits Of The Worlds Most Widely Used Beverage
7. Drug In Asthma inhaler Found To Counteract Benefits
8. The Benefits Of Keyhole Surgery
9. The Benefits Of A Stretch
10. A Reduction In Calories Found To Yield More Benefits
11. The Benefits Of Soy
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/3/2016)... ... ... Boston Children’s Hospital today announced its new pediatric Simulation (SIM) Center — ... procedures in an environment that looks and feels real. , Located in the heart ... “hackers” to develop and test new devices or software platforms and see how they ...
(Date:5/3/2016)... Dallas, Texas (PRWEB) , ... May 03, 2016 , ... ... that live in or adjacent to the 75204, 75205, 75206, 75209, 75219, 75220, ... Oak Lawn/Uptown, Greenway Parks, Bluffview, Midway Hollow, North Dallas, Plano, Preston Hollow and Park ...
(Date:5/3/2016)... ... May 03, 2016 , ... Intrigma, the leading ... Legacy Health is expanding its use of Intrigma’s cloud-based physician scheduling solution, Efficient ... proof of concept. The Portland, Oregon based health system conducted a one-year pilot ...
(Date:5/3/2016)... ... May 03, 2016 , ... Dr. Poneh Ghasri, cosmetic dentist ... to both new and existing patients. Cosmetic dentistry allows patients to improve the aesthetics ... healthy smiles with some minor or more serious cosmetic flaws. These specials allow patients ...
(Date:5/3/2016)... ... 03, 2016 , ... Branches, Inc. is proud to have been selected as ... programs in South Miami. Macy’s is a wonderful community partner and has helped to ... tutoring, mentoring, enrichment and academic support to elementary students 5 days a week. Summer ...
Breaking Medicine News(10 mins):
(Date:5/2/2016)... 2, 2016 The global  ... 11.1 billion by 2024, according to a new ... drivers of the sonography market include expanding applications ... recommendations for periodic ultrasound screenings of the breast ... http://photos.prnewswire.com/prnh/20150105/723757 ) High Intensity Focused ...
(Date:4/29/2016)... -- Glycotope GmbH, a clinical-stage immuno-oncology company ... of Dr. Alfredo Zurlo as Chief Medical ... many years clinical experience and a proven track record ... was at Mologen AG where he was Chief Medical ... Zurlo held various positions at F Hoffmann La Roche ...
(Date:4/28/2016)... April 28, 2016  Marking its one year ... and ovarian cancer risk test, Color Genomics ... genes that highly impact the most common hereditary ... the Color Test analyzes hereditary cancer risks for ... uterine cancers. The Color Test is physician ordered ...
Breaking Medicine Technology: